Comparison of clinical and angiographic results in COVID-19-positive and -negative patients undergoing primary coronary intervention due to ST-elevation myocardial infarction
dc.contributor.author | Emren, Zeynep | |
dc.contributor.author | Gediz, Rahman | |
dc.contributor.author | Levent, Fatih | |
dc.contributor.author | Emren, Sadik | |
dc.contributor.author | Senoz, Oktay | |
dc.date.accessioned | 2025-03-20T09:45:09Z | |
dc.date.available | 2025-03-20T09:45:09Z | |
dc.date.issued | 2021 | |
dc.department | İzmir Bakırçay Üniversitesi | |
dc.description.abstract | Introduction: Although coronavirus disease-19 (COVID-19) primarily causes respiratory system infection, it may cause thrombosis in the cardiovascular system. In this regard, we aimed to compare cardiovascular outcomes between COVID-19-positive and -negative patients with ST-segment elevation myocardial infarction (STEMI). Methods: This was a retrospective study that consecutively included 96 COVID - and 36 COVID+ patients with STEMI. Clinical, laboratory, and angiographic characteristics were obtained from hospital records, and these variables were compared between groups. Results: COVID-19 patients with STEMI had higher Killip score (3-4) (78 vs. 30, P < 0.001) and mortality (42% vs. 21%, P = 0.017). Among COVID-19 patients with STEMI, 83% had lung infiltration. According to the angiographic findings, COVID-19 patients had a shorter door to balloon time (35 ± 20 vs. 49 ± 17, P = 0.013), glycoprotein IIb/IIIa antagonist use, and shorter door to balloon time. Conclusion: COVID-19 patients with STEMI had a higher rate of cardiogenic shock and mortality. © 2021 Society of Cardiovascular Academy. All rights reserved. | |
dc.identifier.doi | 10.4103/ijca.ijca_18_21 | |
dc.identifier.endpage | 82 | |
dc.identifier.issn | 2405-819X | |
dc.identifier.issue | 3 | |
dc.identifier.scopus | 2-s2.0-85187100663 | |
dc.identifier.scopusquality | Q4 | |
dc.identifier.startpage | 78 | |
dc.identifier.uri | https://doi.org/10.4103/ijca.ijca_18_21 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14034/2144 | |
dc.identifier.volume | 7 | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | en | |
dc.publisher | Wolters Kluwer Medknow Publications | |
dc.relation.ispartof | International Journal of the Cardiovascular Academy | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_Scopus_20250319 | |
dc.subject | Acute coronary syndrome | |
dc.subject | coagulopathy | |
dc.subject | coronavirus disease-19 | |
dc.subject | severe acute respiratory system syndrome coronavirus-2 | |
dc.subject | ST-segment elevation myocardial infarction | |
dc.title | Comparison of clinical and angiographic results in COVID-19-positive and -negative patients undergoing primary coronary intervention due to ST-elevation myocardial infarction | |
dc.type | Article |